Thomson Medical (SGX:A50) booked a loss attributable to owners of the company of SG$12.9 million for the six months ended Dec. 31, 2024, against an attributable profit of SG$2.0 million a year earlier, a filing with the Singapore Exchange said on Wednesday.
Loss per share came in at SG$0.00049 compared with earnings per share of SG$0.00008 in the comparable period.
Revenue was, however, up 18% year over year to SG$199.1 million from SG$168.1 million.